维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Lobenberg R"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Modern bioavailability, bioequivalence and biopharmaceutics classification system: new scientific approaches to international regulatorystandards显示文摘	Lobenberg R Amidon GL	2000	Eurj Pharm Biopharm2000，50，：	1
2	Macrophage targeting of azidothymidine:a promising strategy for AIDS therapy显示文摘	Lobenberg R Kreuter J	1996	AIDS Res Hum Retroviruses1996，12，18：	1
3	Biorelevant dissolution media as a predictive tool for glyburide a class Ⅱ drug显示文摘	WEI H LOBENBERG R	2006	Eur J Pharm Sci2006，29，1：	1
4	Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro显示文摘	Alyaudtin RN Reichel A Lobenberg R	2001	J Drug Target2001，9，3：	1
5	Influence of the surfactant concentration on the body distribution of nanopariticles显示文摘	Araujo L Lobenberg R Kreuter J	1999	J Drug Targeting1999，6，5：	1
6	Current perspectives in dissolution testing of conventional and novel dosage forms显示文摘	Azarmi S Roa W Lobenberg R	2007	Int J Pharm2007，328，1：	1
7	Current perspectives in dissolu- tion testing of conventional and novel dosage forms 显示文摘	Azanni S Roa W Lobenberg R	2007	Int J Pharm2007，328，1：	1
8	Macrophage targeting of azidothymidine:a promising strategy for AIDS therapy 显示文摘	Lobenberg R Kreuter J	1996	AIDS Res Hum Retrovir1996，12，：	1
9	Improved body distribution of 14C-labelled AZT bound to nanoparticles in rats determined by radioluminography显示文摘	Lobenberg R Mass J Kreuter J	1998	J Drug Target1998，5，3：	1
10	Dynamic dissolution testing to establish in vitro~in vivo correlations for montelukast so- dium, a poorly soluble drug 显示文摘	OKUMU A DIMASO M LOBENBERG R	2008	Pharm Res2008，25，12：	1
11	Targeted delivery of nanopartieles for the treatment of lung diseases 显示文摘	Azarmi S Roa W H Lobenberg R	2008	Adv Drug Deliv Rev2008，60，8：	1
12	Current perspectives in dissolution testing of conventional and novel dosage forms 显示文摘	Azarmi S Roa W Lobenberg R	2007	Int J Pharm2007，328，1：	1
13	Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenelamide 显示文摘	Lobenberg R Kramer J Shah VP	2000	Pharm Res2000，17，4：	1
14	Dynamic dissolution testing to establish in vitro/in vivo correlations for montelukast sodium, a poorly soluble drug 显示文摘	Okumu A DiMaso M Lobenberg R	2008	Pharm Res2008，25，12：	1
15	Biorelevant dissolution media as a predictive tool for glyburide a class II drug 显示文摘	Wei H Lobenberg R	2006	Eur J Pharm Sci2006，29，1：	1
16	Body distribution of azidothymidine bound to nanoparticles after oral administration 显示文摘	Lobenberg R Araujo L Kreuter J	1997	Eur J Pharm Biopharm1997，44，：	1
17	Dynamic dissolution testing to establish in vitro-in vivo correlations for montelukast so- dium, a poorly soluble drug 显示文摘	OKUMU A Di MASO M LOBENBERG R	2008	Pharm Res2008，25，12：	1
18	Interaction of poly-butylcyanoacrylate nanoparticles with the blood-brain barrier in vivo and in vitro显示文摘	ALYAUTDIN RN REICHEL A LOBENBERG R	2001	J Drug Target2001，9，3：	1
19	Body distribution of azidothymidine bound to nanoparticles after oral administration显示文摘	LOBENBERG R ARAUJO L KREUTER J	1997	Eur J Pharm Biopharm1997，44，：	1
20	Influence of the surfactant concentration on the body distribution of nanoparticles显示文摘	Lobenberg R Kreuter J	1999	J Drug Target1999，6，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示